Skip to content
OpenCapital
Get started

Denali Therapeutics Inc. DNLI Q1 2026 earnings

Reported May 7, 2026 · Before market open

EPS-$0.69Beat by $0.04
Revenue estimate$2.6M
EPS estimate-$0.73

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$2.2M
EPS estimate-$0.54

Financials

Q1 2026

Income statement

See full
Operating income-$137.4M+5.6%
Net income-$128.4M+3.4%
EPS (diluted)-$0.69+11.5%

Balance sheet

See full
Cash & equivalents$390.7M+551%
Total debt$40.0M-22.3%
Total equity$926.1M-17.5%
Total assets$1.3B-0.4%

Cash flow

See full
Operating cash flow-$131.2M+0.2%
CapEx$2.5M-51.4%
Free cash flow-$133.7M+2.1%

Valuation & ratios

Valuation

as of 07/28/26
See full
Market cap$3.74B+88.9%
Enterprise value$3.39B+80.0%

Returns & leverage

See full
Return on equity-49.6%+34.2pp
Debt / equity0×0.0×
Current ratio9.3×-0.3×

Segments

By product

See full
Milestone Triggered$25.0M0.0%
Milestone Payment$2.5M0.0%
Option Fee Payment$2.5M+100%

Versus estimates

Diluted EPS

Q1 2026-$0.69Beat by $0.04
Q4 2025-$0.73Beat by $0.02Q3 2025-$0.74Beat by $0.02Q2 2025-$0.72Beat by $0.02Q1 2025-$0.78Miss by $0.07Q4 2024-$0.67Beat by $0.08

Ask the moment Denali Therapeutics Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Denali Therapeutics Inc. report Q1 2026 earnings?
Denali Therapeutics Inc. (DNLI) reported Q1 2026 earnings on May 7, 2026 before market open.
What were Denali Therapeutics Inc.'s Q1 2026 revenue and EPS?
Denali Therapeutics Inc. reported eps of $-0.69 for Q1 2026.
Did Denali Therapeutics Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.73 by $0.04.
How did Denali Therapeutics Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 11.5% from $-0.78.
Where can I find Denali Therapeutics Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001714899-26-000062) and the 10-Q periodic report (0001714899-26-000064) directly on SEC EDGAR. The filing index links above go to sec.gov.